This is a StreetInsider.com Premium Only Page

Luminex Corp. (LMNX) – PRNewswire

Jul 12, 2021 06:26 PM Middlesex Water Set to Join S&P SmallCap 600

May 20, 2021 04:30 PM Luminex Corporation Declares Second Quarter Cash Dividend

Apr 12, 2021 10:51 AM DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion

Mar 10, 2021 06:30 AM Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization

Mar 9, 2021 11:35 AM Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference

Mar 4, 2021 06:30 AM Luminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2

Feb 19, 2021 06:30 AM Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel

Feb 8, 2021 04:01 PM Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results

Feb 8, 2021 01:00 PM Luminex Corporation Declares First Quarter Cash Dividend

Jan 27, 2021 07:00 AM Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021

Jan 13, 2021 11:14 AM Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference

Jan 12, 2021 06:00 AM Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue

Dec 16, 2020 02:23 PM Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference

Dec 7, 2020 10:59 AM Luminex Corporation Declares Fourth Quarter Cash Dividend

Nov 5, 2020 04:02 PM Luminex Corporation Reports Strong Third Quarter 2020 Results

Oct 22, 2020 07:00 AM Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020

Oct 7, 2020 07:00 AM Luminex Corporation Pre-Release of 3rd Quarter 2020 Revenue

Sep 24, 2020 04:05 PM Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2

Sep 23, 2020 04:05 PM Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test

Sep 15, 2020 07:30 AM Luminex Corporation Declares Third Quarter Cash Dividend

Aug 4, 2020 04:15 PM Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors

Aug 4, 2020 04:01 PM Luminex Corporation Reports Second Quarter 2020 Results

Jul 22, 2020 05:00 AM Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2

Jul 20, 2020 01:16 PM Luminex Corporation Second Quarter Earnings Release Rescheduled for August 4, 2020

Jul 20, 2020 05:00 AM Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test

Jul 8, 2020 09:46 AM Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue

Jul 8, 2020 07:00 AM Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue

Jul 1, 2020 05:00 AM Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners

Jun 29, 2020 04:01 PM Luminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody Test

May 22, 2020 07:00 AM Luminex Corporation Declares Second Quarter Cash Dividend

May 8, 2020 07:00 AM Luminex Corporation Announces Pricing Of Offering Of $260 Million Of 3.00% Convertible Senior Notes Due 2025

May 4, 2020 04:05 PM Luminex Corporation Reports First Quarter 2020 Results

Apr 22, 2020 08:30 AM Luminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020

Apr 6, 2020 04:30 PM Luminex Corporation Pre-Release of 1st Quarter Revenue

Apr 6, 2020 07:30 AM Luminex Receives FDA Emergency Use Authorization for ARIES® SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 Disease

Mar 31, 2020 07:30 AM Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test

Mar 27, 2020 04:05 PM Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease

Mar 13, 2020 07:30 AM Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts

Mar 4, 2020 07:30 AM Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus

Feb 24, 2020 09:00 AM Luminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA Clearance

Feb 18, 2020 11:57 AM Luminex Corporation Declares First Quarter Cash Dividend

Feb 13, 2020 03:10 PM Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020

Feb 10, 2020 04:03 PM Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results

Jan 23, 2020 09:02 AM Luminex Corporation To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020

Jan 12, 2020 05:00 PM Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference

Dec 6, 2019 12:20 PM Luminex Corporation Declares Fourth Quarter Cash Dividend

Nov 25, 2019 09:00 AM Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019

Nov 4, 2019 03:46 PM Luminex Corporation Reports Third Quarter 2019 Results and Submission of VERIGENE II Gastrointestinal Flex Assay to the FDA

Oct 25, 2019 03:43 PM Luminex Corporation To Release Third Quarter 2019 Results After Market Close On November 4, 2019

Oct 1, 2019 09:05 AM Luminex Receives FDA 510(k) Clearance for the ARIES® MRSA Assay